Metformin News and Research

RSS

Metformin is the active ingredient in a drug used to treat diabetes mellitus (a condition in which the body cannot control the level of sugar in the blood). It is also being studied in the treatment of cancer. It decreases the amount of glucose (a type of sugar) released into the bloodstream from the liver and increases the body’s use of the glucose. Metformin is a type of antidiabetic agent.

Semaglutide linked to increased risk of severe eye condition NAION in new study

Research shows semaglutide users face a significantly higher risk of developing non-arteritic anterior ischemic optic neuropathy (NAION) compared to users of other medications for diabetes and obesity.

8 Jul 2024

GLP-1 drugs found to lower cancer risk in diabetes patients

Research finds that GLP-1 receptor agonists significantly reduce the risk of 10 out of 13 obesity-associated cancers in type 2 diabetes patients compared to insulins, but show varied results against metformin.

8 Jul 2024

PCOS linked to higher risk of adverse birth outcomes

The association between polycystic ovary syndrome (PCOS) and birth outcomes in women.

5 Jul 2024

Researchers identify key osteoporosis-related gene and develop new mouse model of the disease

Osteoporosis-;weakening of the bones with age-;affects millions worldwide, and this figure is increasing annually as the global population ages.

1 Jul 2024

Natural compound found in olives can lower blood sugar levels and promote weight loss

Findings from a new mouse study suggest that elenolic acid, a natural compound found in olives, can lower blood sugar levels and promote weight loss.

29 Jun 2024

Diabetes decoded: How your gut microbiome influences disease risk

How microbial features and functions specific to subspecies and strains contribute to the pathological mechanisms of type 2 diabetes.

27 Jun 2024

Differences in effectiveness among antihyperglycemic drugs on dementia risk identified in recent study

Researchers compare the effectiveness of anti-diabetes medications in reducing the risk of dementia in older diabetics.

26 Jun 2024

Mouse models inform potential treatments for Fragile X, Phelan-McDermid syndromes

Studies of mouse models of Fragile X syndrome and Phelan-McDermid syndrome show that treatment with cannabidiol (CBD) and the diabetes drug metformin can alleviate behavioral difficulties, according to research presented today (Wednesday) at the Federation of European Neuroscience Societies (FENS) Forum 2024.

26 Jun 2024

Semaglutide reduces heart risks in overweight and obese individuals without diabetes

The SELECT trial found that semaglutide significantly reduces cardiovascular events in individuals with overweight or obesity and preexisting cardiovascular disease, regardless of baseline HbA1c or changes in HbA1c levels.

26 Jun 2024

Semaglutide proves a game-changer for kidney and heart health in diabetes patients

The FLOW trial demonstrated that semaglutide significantly improves kidney and cardiovascular outcomes in people with chronic kidney disease and type 2 diabetes, irrespective of SGLT2 inhibitor use.

25 Jun 2024

Targeting the gut microbiome: A new approach to treating diabetes

Researchers review the role of gut microbiota in the pathogenesis and management of diabetes mellitus.

24 Jun 2024

Intermittent fasting outperforms traditional drugs in managing early type 2 diabetes

Study shows that a 5:2 intermittent fasting meal replacement diet effectively controls blood glucose levels and reduces body weight in Chinese adults with early type 2 diabetes. This dietary intervention outperforms metformin and empagliflozin in managing diabetes and obesity.

24 Jun 2024

Oral semaglutide proves effective for type 2 diabetes and weight loss in Dutch study

A recent study from the PIONEER REAL Netherlands trial demonstrated that oral semaglutide effectively manages type 2 diabetes and supports weight loss in adults.

18 Jun 2024

Integration of genomics, epigenomics, and transcriptomics in understanding Alzheimer's pathogenesis

With the advent of new omics technologies in recent years, there has been a deluge of complex, high-dimensional data on Alzheimer's disease (AD).

12 Jun 2024

Innovative therapeutic strategies for combating type 2 diabetes

One of the most confusing aspects for patients with type 2 diabetes mellitus is that they have high fasting glucose levels.

7 Jun 2024

Common drugs linked to reduced risk of bleeding stroke from brain aneurysm

A new study suggests that people who take a few common drugs may have a decreased risk of having a bleeding stroke due to a ruptured brain aneurysm.

5 Jun 2024

Long-term study reveals safety of metformin use during pregnancy

Metformin is safe to use during pregnancy to manage diabetes, with no long-term adverse effects on the children born and their mothers for at least 11 years after childbirth, according to research presented Sunday at ENDO 2024, the Endocrine Society's annual meeting in Boston, Mass.

3 Jun 2024

Metformin News and Research

Further Reading

Semaglutide linked to increased risk of severe eye condition NAION in new study

GLP-1 drugs found to lower cancer risk in diabetes patients

PCOS linked to higher risk of adverse birth outcomes

Researchers identify key osteoporosis-related gene and develop new mouse model of the disease

Natural compound found in olives can lower blood sugar levels and promote weight loss

Diabetes decoded: How your gut microbiome influences disease risk

Differences in effectiveness among antihyperglycemic drugs on dementia risk identified in recent study

Mouse models inform potential treatments for Fragile X, Phelan-McDermid syndromes

Semaglutide reduces heart risks in overweight and obese individuals without diabetes

Semaglutide proves a game-changer for kidney and heart health in diabetes patients

Targeting the gut microbiome: A new approach to treating diabetes

Intermittent fasting outperforms traditional drugs in managing early type 2 diabetes

Oral semaglutide proves effective for type 2 diabetes and weight loss in Dutch study

Integration of genomics, epigenomics, and transcriptomics in understanding Alzheimer's pathogenesis

Innovative therapeutic strategies for combating type 2 diabetes

Common drugs linked to reduced risk of bleeding stroke from brain aneurysm

Long-term study reveals safety of metformin use during pregnancy

Oral semaglutide shows significant promise in improving diabetes control and cardiovascular health, study reveals

Oral semaglutide shows promising results for type 2 diabetes in routine clinical settings

Metformin use linked to reduced risk of myeloproliferative neoplasms

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Automating research - solutions and best practices

Latest News